Sector exposure

Biotechnology -0.04pp 7D

1,009 funds with Biotechnology exposure · showing top 10 · average allocation in displayed funds 87.3%

Funds
10
Avg weight
87.3%
Sector Signals · Biotechnology Rule-based · derived from FMP & FE data
Generating analysis…

AI outlook will appear here once data is loaded.

Momentum
Valuation
Fund sentiment
community voting · coming soon
Build a screen from this →

Top Biotechnology-exposed funds

Sorted by sector weight · 10 funds total
Fund
Manager
Sector weight
1Y return
WH
Worldwide Healthcare Trust PLC
GB00BN455J50
Frostrow Capital LLP
100%
+18.7%
IN
iShares Nasdaq US Biotechnology UCITS ETF
IE00BDZVHG35
BlackRock
100%
+46.8%
GX
Global X S&P Biotech ETF
AU0000028110
Global X ETFs
100%
+72.3%
B
Biotech
LU0090689299
Pictet
100%
+65.8%
SS
State Street SPDR S&P Biotech ETF
US78464A8707
SPDR ETFs
99.9%
+74.1%
JH
Janus Henderson Horizon Biotechnology Fund
LU1897414485
Janus Henderson Investors
88.7%
+72.4%
FB
Franklin Biotechnology Discovery Fund
LU0122613499
Franklin Templeton
77.3%
+78.9%
MB
MEDICAL BioHealth
LU0228344361
Hauck Aufhäuser
71.6%
+45.4%
HS
HealthInvest Small & Mid Cap Healthcare
SE0012622231
HealthInvest Partners
69.1%
+28.9%
AM
apo Medical Opportunities
LU0220663669
IPConcept
66.5%
+20.5%
Top Biotechnology Holdings Across Funds
BOUYGUES SA
Unknown
35.33%
in 1 funds
BIOTECH M&A TARGET SWAP
Unknown
11.3%
in 1 funds
LLY
ELI LILLY AND COMPANY
Drug Manufacturers - General
7.62%
in 2 funds
PRAXIS PRECISION MEDICINES
Unknown
6.39%
in 1 funds
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
Unknown
6.14%
in 1 funds
AMGEN INC.
Unknown
5.74%
in 2 funds
PROTAGONIST THERAPEUTICS INC.
Unknown
5.63%
in 1 funds
GILEAD SCIENCES, INC.
Unknown
5.23%
in 3 funds
Conviction Score vs MSCI Benchmark
Fund weight vs MSCI World benchmark (0%)
Worldwide Healthcare..
+100%
iShares Nasdaq US Bi..
+100%
Global X S&P Biotech..
+100%
Biotech
+100%
State Street SPDR S&..
+99.9%
Janus Henderson Hori..
+88.7%
Franklin Biotechnolo..
+77.3%
MEDICAL BioHealth
+71.6%
HealthInvest Small &..
+69.1%
apo Medical Opportun..
+66.5%
Performance Chart
Top 10-fund composite (rebased to 100, equal-weighted) Real fund NAV data 2025-06-24 → 2026-05-29
Biotechnology Sector News
Loading news...